Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma

  • Authors:
    • Deliang Yu
    • Jing Zhao
    • Yuhong Wang
    • Jing Hu
    • Qinchuan Zhao
    • Jibin Li
    • Jianjun Zhu
  • View Affiliations

  • Published online on: April 16, 2019     https://doi.org/10.3892/or.2019.7119
  • Pages: 3347-3354
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Histamine receptor H3 (HRH3) is mainly expressed in the central nervous system, where it is involved in the regulation of the release of various neurotransmitters in the brain. Recent studies have demonstrated that the expression of HRH3 is upregulated in several types of cancer. However, the functional effect of HRH3 on tumor progression remains largely unknown, particularly in hepatocellular carcinoma (HCC). In the present study, the expression of HRH3 in 96 HCC patients was first evaluated, and its clinical significance was analyzed. Subsequently, the functional roles of HRH3 in HCC growth and metastasis were systematically explored in vitro and in vivo using its agonist (imetit) or antagonist (clobenpropit). It was observed that HRH3 was significantly upregulated in HCC tissues, while its expression was significantly associated with recurrence‑free survival and overall survival in HCC patients. Functional experiments also demonstrated that HRH3 upregulation facilitated the growth and metastasis of HCC cells by inducing the formation of lamellipodia. These findings revealed that HRH3 serves an important role in the growth and metastasis of HCC cells, which provides experimental evidence supporting the application of HRH3 as a potential therapeutic target in HCC treatment.

References

1 

Singh M and Jadhav HR: Histamine H3 receptor function and ligands: Recent developments. Mini Rev Med Chem. 13:47–57. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Coruzzi G, Adami M and Pozzoli C: Role of histamine H4 receptors in the gastrointestinal tract. Front Biosci. 4:226–239. 2012. View Article : Google Scholar

3 

Hegyesi H, Darvas Z, László V, Pós Z, Pállinger E, Hirschberg K, Kovács P and Falus A: Retinoic acid enhances histamine content and H1 receptor expression in human neuroblastoma cell line Paju. Anticancer Res. 24:1657–1663. 2004.PubMed/NCBI

4 

Kitakaze M: Clinical evidence of the role of histamine in heart failure. J Am Coll Cardiol. 67:1553–1555. 2016. View Article : Google Scholar : PubMed/NCBI

5 

de Esch IJ, Thurmond RL, Jongejan A and Leurs R: The histamine H 4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci. 26:462–469. 2005.PubMed/NCBI

6 

Medina VA and Rivera ES: Histamine receptors and cancer pharmacology. Brit J Pharmacol. 161:755–767. 2010. View Article : Google Scholar

7 

Chen Y, Zhen W, Guo T, Zhao Y, Liu A, Rubio JP, Krull D, Richardson JC, Lu H and Wang R: Histamine receptor 3 negatively regulates oligodendrocyte differentiation and remyelination. PLoS One. 12:e1893802017. View Article : Google Scholar

8 

Bhowmik M, Khanam R and Vohora D: Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: A systemic consideration of recent progress and perspectives. Brit J Pharmacol. 167:1398–1414. 2012. View Article : Google Scholar

9 

Yang XD, Ai W, Asfaha S, Bhagat G, Friedman RA, Jin G, Park H, Shykind B, Diacovo TG, Falus A and Wang TC: Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med. 17:87–95. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Tanaka T, Kochi T, Shirakami Y, Mori T, Kurata A, Watanabe N, Moriwaki H and Shimizu M: Cimetidine and clobenpropit attenuate inflammation-associated colorectal carcinogenesis in male ICR mice. Cancers. 8(pii): E252016. View Article : Google Scholar : PubMed/NCBI

11 

Wong MC, Jiang JY, Goggins WB, Liang M, Fang Y, Fung FD, Leung C, Wang HH, Wong GL, Wong VW, et al: International incidence and mortality trends of liver cancer: A global profile. Sci Rep. 7:458462017. View Article : Google Scholar : PubMed/NCBI

12 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Huang Q, Lei Z, Cao H, Li J, Lyu Y, Guo X, Zhang J, Ji L, Ren T, An J, et al: Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 12:999–1014. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Zhu J, Jin M, Wang J, Zhang H, Wu Y, Li D, Ji X, Yang H, Yin C, Ren T, et al: TNFα induces Ca2+ influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells. J Exp Clin Canc Res. 37:432018. View Article : Google Scholar

15 

Medina V, Croci M, Crescenti E, Mohamad N, Sanchez-Jiménez F, Massari N, Nuñez M, Cricco G, Martin G, Bergoc R, et al: The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol Ther. 7:28–35. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Szabó PM, Wiener Z, Tömböl Z, Kovács A, Pócza P, Horányi J, Kulka J, Riesz P, Tóth M, Patócs A, et al: Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors. Virchows Arch. 455:133–142. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Lin JJ, Zhao TZ, Cai WK, Yang YX, Sun C, Zhang Z, Xu YQ, Chang T and Li ZY: Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition. Oncotarget. 6:17107–17120. 2015.PubMed/NCBI

18 

He GH, Lin JJ, Cai WK, Xu WM, Yu ZP, Yin SJ, Zhao CH and Xu GL: Associations of polymorphisms in histidine decarboxylase, histamine N-methyltransferase and histamine receptor H3 genes with breast cancer. PLoS One. 9:e977282014. View Article : Google Scholar : PubMed/NCBI

19 

Tanaka S, Sakaguchi M, Yoneyama H, Usami Y and Harusawa S: Histamine H3 receptor antagonist OUP-186 attenuates the proliferation of cultured human breast cancer cell lines. Biochem Biophys Res Commun. 480:479–485. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Cricco GP, Mohamad NA, Sambuco LA, Genre F, Croci M, Gutiérrez AS, Medina VA, Bergoc RM, Rivera ES and Martín GA: Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors. Inflamm Res. 57 (Suppl 1):S23–S24. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Francis H, Onori P, Gaudio E, Franchitto A, DeMorrow S, Venter J, Kopriva S, Carpino G, Mancinelli R, White M, et al: H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo. Mol Cancer Res. 7:1704–1713. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Francis H, Franchitto A, Ueno Y, Glaser S, DeMorrow S, Venter J, Gaudio E, Alvaro D, Fava G, Marzioni M, et al: H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest. 87:473–487. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Davenas E, Rouleau A, Morisset S and Arrang JM: Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors. J Pharmacol Exp Ther. 326:406–413. 2008. View Article : Google Scholar : PubMed/NCBI

24 

Kennedy L, Hodges K, Meng F, Alpini G and Francis H: Histamine and histamine receptor regulation of gastrointestinal cancers. Transl Gastrointest Cancer. 1:215–227. 2012.PubMed/NCBI

25 

Grandi D, Schunack W and Morini G: Epithelial cell proliferation is promoted by the histamine H3 receptor agonist (R)-α-methylhistamine throughout the rat gastrointestinal tract. Eur J Pharmacol. 538:141–147. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Medina V, Cricco G, Nuñez M, Martín G, Mohamad N, Correa-Fiz F, Sanchez-Jimenez F, Bergoc R and Rivera ES: Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol Ther. 5:1462–1471. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Machesky LM: Lamellipodia and filopodia in metastasis and invasion. Febs Lett. 582:2102–2111. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Brown MC, Perrotta JA and Turner CE: Serine and threonine phosphorylation of the paxillin LIM domains regulates paxillin focal adhesion localization and cell adhesion to fibronectin. Mol Biol Cell. 9:1803–1816. 1998. View Article : Google Scholar : PubMed/NCBI

29 

Huang C, Jacobson K and Schaller MD: A role for JNK-paxillin signaling in cell migration. Cell Cycle. 3:4–6. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Ren T, Zhang H, Wang J, Zhu J, Jin M, Wu Y, Guo X, Ji L, Huang Q, Zhang H, et al: MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells. Oncogene. 36:5897–5909. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 41 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yu, D., Zhao, J., Wang, Y., Hu, J., Zhao, Q., Li, J., & Zhu, J. (2019). Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma. Oncology Reports, 41, 3347-3354. https://doi.org/10.3892/or.2019.7119
MLA
Yu, D., Zhao, J., Wang, Y., Hu, J., Zhao, Q., Li, J., Zhu, J."Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma". Oncology Reports 41.6 (2019): 3347-3354.
Chicago
Yu, D., Zhao, J., Wang, Y., Hu, J., Zhao, Q., Li, J., Zhu, J."Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma". Oncology Reports 41, no. 6 (2019): 3347-3354. https://doi.org/10.3892/or.2019.7119